Clinical Trials Containment Doctors FDA Approval 
The Pharma Data
DECEMBER 12, 2020
As for the vaccines, Pfizer will ship them in specially designed containers packed with dry ice, to keep the temperature inside at minus 94 degrees Fahrenheit. Each container will have a tracking device and a thermal probe, to make sure no vaccine doses are lost or degraded. The emergency approval comes not a moment too soon.
The Pharma Data
JANUARY 20, 2021
FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction. The Verquvo label contains a boxed warning that indicates that Verquvo should not be administered to pregnant females because it may cause fetal harm. KENILWORTH, N.J.–(BUSINESS Verquvo (vericiguat) 2.5
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 15, 2021
Food and Drug Administration (FDA) approval of Darzalex Faspro ® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1]
XTalks
DECEMBER 20, 2023
Novo Nordisk’s GLP-1 weight loss-specific drug Wegovy (semaglutide) has been facing similar shortages, as it contains the same active ingredient as Ozempic. The ad followed GSK’s earlier campaign featuring Magic Johnson , aiming to raise awareness about RSV following Arexvy’s FDA approval in May 2023 for adults 60 years of age and older.
XTalks
NOVEMBER 9, 2022
Since Mounjaro’s May US Food and Drug Administration (FDA) approval, sales of the drug have skyrocketed beyond initial expectations owing to patient demand and a temporary shortage of Novo’s Ozempic. Mounjaro and Ozempic are both FDA approved for glycemic control in adults with type 2 diabetes, in combination with diet and exercise.
Delveinsight
OCTOBER 1, 2021
Myasthenia Gravis Approved Therapies. The current Myasthenia Gravis therapeutics market has many FDA-approved drugs for the treatment of Myasthenia Gravis. Some of the approved drugs are: Prograf (Tacrolimus). Prograf is available for oral administration in the form of capsules (tacrolimus capsules USP) containing 0.5
The Pharma Data
JULY 21, 2021
Food and Drug Administration (FDA) approved VERQUVO in the U.S. the product label for VERQUVO contains a boxed warning that indicates that VERQUVO should not be administered to pregnant females because it may cause fetal harm. In the U.S., About VERQUVO ® (vericiguat) tablets for once daily oral use (2.5 mg, 5 mg and 10 mg).
Expert insights. Personalized for you.
52 
Let's personalize your content